First-In-Human Experience of the New Fully Repositionable IMPERIA Delivery System to Implant the ALLEGRA Transcatheter Heart Valve in Patients With Severe Calcific Aortic Stenosis or Degenerated Surgical Bioprosthesis: Thirty-Day Results of the EMPIR

This study confirms the safety and efficacy of transcatheter aortic valve implantation using the IMPERIA delivery system to implant the CE marked ALLEGRA transcatheter heart valve in patients with severe calcific native AS or a degenerated surgical aortic bioprostheses.

Authors

Nicolas M. Van Mieghem (ORCID: https://orcid.org/0000-0002-2732-1205)
Pim A.L. Tonino (ORCID: https://orcid.org/0000-0002-2099-5426)
Joseph M. Graham (ORCID: https://orcid.org/0009-0002-7541-4892)
Samuel Copt (ORCID: https://orcid.org/0000-0001-8378-9729)
Christian Frerker (ORCID: https://orcid.org/0000-0003-0226-0888)
José M. de la Torre Hernández (ORCID: https://orcid.org/0000-0003-4570-8902)
Christof Burgdorf (ORCID: https://orcid.org/0000-0002-8130-2443)
José Antonio Baz
Keith G. Oldroyd (ORCID: https://orcid.org/0000-0002-7842-3463)
Pieter A. Vriesendorp (ORCID: https://orcid.org/0000-0002-2961-8600)
Ignacio Cruz‐González (ORCID: https://orcid.org/0000-0001-9742-6072)
Ben Ren (ORCID: https://orcid.org/0000-0002-8227-8094)
Ernest Spitzer (ORCID: https://orcid.org/0000-0003-2371-5431)
Anders Jönsson
Nicolas Doll
Pilar Jiménez

Institutions

Radboud University Nijmegen (NL)
Royal Sussex County Hospital (GB)
Catharina Ziekenhuis (NL)
Erasmus MC (NL)
Bellvitge University Hospital (ES)
University Hospital Complex Of Vigo (ES)
Hospital Clínico San Carlos (ES)
Maastricht University (NL)
Universitäres Kinderwunschzentrum Lübeck (DE)
Complejo Hospitalario de Salamanca (ES)
Schüchtermann-Klinik (DE)
Klinik Lüneburger Heide (DE)
Hospital Clínico Universitario Virgen de la Victoria (ES)
Cardialysis (Netherlands) (NL)
University of Lübeck (DE)

Publication Details

Journal: Structural Heart
Published: 2025-02-06
DOI: https://doi.org/10.1016/j.shj.2024.100391
Citations: 2
Primary Topic: Cardiac Valve Diseases and Treatments
Type: article
Field-Weighted Citation Impact: 2.78

Funders

Edwards Lifesciences
Boston Scientific Corporation
MicroPort

First-In-Human Experience of the New Fully Repositionable IMPERIA Delivery System to Implant the ALLEGRA Transcatheter Heart Valve in Patients With Severe Calcific Aortic Stenosis or Degenerated Surgical Bioprosthesis: Thirty-Day Results of the EMPIR

Nicolas M. Van Mieghem, Pim A.L. Tonino, Joseph M. Graham, Samuel Copt, Christian Frerker, José M. de la Torre Hernández, Christof Burgdorf, José Antonio Baz, Keith G. Oldroyd, Pieter A. Vriesendorp, Ignacio Cruz‐González, Ben Ren, Ernest Spitzer, Anders Jönsson, Nicolas Doll, Pilar Jiménez

February 6, 2025article en

2 citations

First-In-Human Experience of the New Fully Repositionable IMPERIA Delivery System to Implant the ALLEGRA Transcatheter Heart Valve in Patients With Severe Calcific Aortic Stenosis or Degenerated Surgical Bioprosthesis: Thirty-Day Results of the EMPIR

Authors

Institutions

Publication Details

Funders

First-In-Human Experience of the New Fully Repositionable IMPERIA Delivery System to Implant the ALLEGRA Transcatheter Heart Valve in Patients With Severe Calcific Aortic Stenosis or Degenerated Surgical Bioprosthesis: Thirty-Day Results of the EMPIR

First-In-Human Experience of the New Fully Repositionable IMPERIA Delivery System to Implant the ALLEGRA Transcatheter Heart Valve in Patients With Severe Calcific Aortic Stenosis or Degenerated Surgical Bioprosthesis: Thirty-Day Results of the EMPIR

Abstract

Ask Laika to Summarize, Analyze, and Connect papers live on the map.